Here are three quick points:
1. Analysts expected second quarter revenue of $21.59 million.
2. Most recently, CEO Daniel S. Goldberger bought 5,000 company shares, at $2.34 per share, on May 10, 2016.
3. Director Kent L. Swanson purchased 3,300 shares, at $2.83 per share, on Dec. 3, 2015.
More articles on devices:
Camber Spine Technologies, Dr. Joseph DiCicco to study SI joint implant Prolix: 5 key notes
Orthopedic, spine device company mergers, acquisitions & partnerships: 8 recent deals
Stryker Performance Solutions launches Episode Performance Manager for TJR procedures: 6 takeaways
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
